Insight Molecular Diagnostics Inc. Common Stock IMDX Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $28.2M+143% | $11.58M-38.0% | $18.69M-23.0% | $24.29M-21.7% | $31.03M+259% | ||
| $729K0.0% | $729K0.0% | $729K-57.1% | $1.7M0.0% | $1.7M— | ||
| $157K-86.1% | $1.13M+337% | $258K-49.6% | $512K-85.5% | $3.54M+119% | ||
| $382K-14.3% | $446K-5.3% | $471K-32.0% | $693K+51.0% | $459K+12.0% | ||
| $1.05M-26.2% | $1.42M+14.6% | $1.24M-8.2% | $1.35M+9.3% | $1.24M+50.4% | ||
| $30.52M+99.4% | $15.31M-28.4% | $21.39M-20.3% | $26.84M-26.0% | $36.26M+208% | ||
| $574K-3.2% | $593K-11.8% | $672K-4.3% | $702K+9.3% | $642K-7.1% | ||
| $40.43M+57.0% | $25.76M-41.4% | $43.94M-13.0% | $50.52M-16.3% | $60.36M+72.1% | ||
| $1.62M-36.5% | $2.54M+141% | $1.06M-17.3% | $1.28M-44.0% | $2.28M+38.9% | ||
| $2.74M-1.6% | $2.78M+24.8% | $2.23M+52.7% | $1.46M-42.2% | $2.52M+296% | ||
| $12.01M-0.6% | $12.08M+57.6% | $7.66M+15.2% | $6.65M-31.3% | $9.68M+33.1% | ||
| $917K-13.5% | $1.06M+6.4% | $996K-1.3% | $1.01M+9.0% | $926K-1.0% | ||
| $1.97M-12.7% | $2.26M+15.7% | $1.95M-10.7% | $2.19M-9.3% | $2.41M-8.2% | ||
| $51.12M-10.7% | $57.22M+7.7% | $53.13M+7.5% | $49.42M-1.4% | $50.14M+5.9% | ||
| $0— | $0— | —— | —— | —— | ||
| $394.29M+6.8% | $369.21M+0.2% | $368.52M+0.2% | $367.97M+0.2% | $367.39M+8.6% | ||
| -$405.05M-1.1% | -$400.76M-6.1% | -$377.81M-3.0% | -$366.95M-2.7% | -$357.21M-1.9% | ||
| $71K-17.4% | $86K0.0% | $86K+1.2% | $85K+107% | $41K+95.2% | ||
| -$10.69M+66.0% | -$31.46M-242% | -$9.2M-938% | $1.1M-89.3% | $10.22M+183% | ||
| $40.43M+57.0% | $25.76M-41.4% | $43.94M-13.0% | $50.52M-16.3% | $60.36M+72.1% | ||
| $574K-3.2% | $593K-11.8% | $672K-4.3% | $702K+9.3% | $642K-7.1% | ||
| $6.45M+0.3% | $6.44M+55.2% | $4.15M0.0% | $4.15M— | —— | ||
| $2.46M-12.6% | $2.82M— | —— | —— | —— | ||
| $574K-3.2% | $593K-11.8% | $672K-4.3% | $702K+9.3% | $642K-7.1% | ||
| $574K-3.2% | $593K-11.8% | $672K-4.3% | $702K+9.3% | $642K-7.1% | ||
| $1.28M+36.7% | $939K+56.0% | $602K+5.4% | $571K-70.4% | $1.93M+361% | ||
| $1.12M0.0% | $1.12M-0.4% | $1.12M+0.4% | $1.12M0.0% | $1.12M0.0% | ||
| $3.33M+35.4% | $2.46M+10.5% | $2.23M+52.7% | $1.46M-42.2% | $2.52M+30.2% | ||
| $3.33M+35.4% | $2.46M+10.5% | $2.23M+52.7% | $1.46M-42.2% | $2.52M+30.2% | ||
| $1.76M-2.5% | $1.81M— | —— | —— | —— | ||
| $2.74M-1.6% | $2.78M— | —— | —— | —— | ||
| $37.81M-13.0% | $43.46M-1.1% | $43.94M+7.4% | $40.93M+6.6% | $38.39M+1.8% | ||
| $2.89M-13.0% | $3.32M+12.5% | $2.95M-7.7% | $3.2M-4.3% | $3.34M-6.3% | ||
| $394.29M+6.8% | $369.21M+0.2% | $368.52M+0.2% | $367.97M+0.2% | $367.39M+8.6% | ||
| $0— | $0— | —— | —— | —— | ||
| $1.12M0.0% | $1.12M-0.4% | $1.12M+0.4% | $1.12M0.0% | $1.12M0.0% | ||
| $1.31M-22.7% | $1.69M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Insight Molecular Diagnostics Inc. Common Stock's total assets?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) holds $40.4M in total assets, down 33.0% year over year.
- How much debt does Insight Molecular Diagnostics Inc. Common Stock have?
- Insight Molecular Diagnostics Inc. Common Stock carries $2.9M in total debt against -$10.7M of shareholders' equity, a debt-to-equity ratio of 2.91.
- How much cash does Insight Molecular Diagnostics Inc. Common Stock have?
- Insight Molecular Diagnostics Inc. Common Stock holds $28.2M in cash and equivalents.
- Can Insight Molecular Diagnostics Inc. Common Stock cover its short-term obligations?
- Its current ratio is 2.54 — current assets exceed current liabilities.
- Where does Insight Molecular Diagnostics Inc. Common Stock's balance sheet data come from?
- Every line is extracted from Insight Molecular Diagnostics Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
